Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia

Clinical trial NCT01919710 · COMPLETED

Trial details

NCT number: NCT01919710
Sponsor: Tianjin SinoBiotech Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Underdose (Unintentional)Cancer Tumor

Start date: 2012-10-01
Primary completion: 2014-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.